[Ref.: #3508] |
Culture collection no. |
DSM 9189, ATCC 49226, CCUG 26213, CDC 10.001, CIP 107031, CCM 4500, CNCTC 5194 |
[Ref.: #79748] |
SI-ID 42367
|
* |
|
Literature: |
Only first 10 entries are displayed. Click here to see all.Click here to see only first 10 entries. |
|
Topic |
Title |
Authors |
Journal |
DOI |
Year |
|
Pathogenicity |
In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae. |
Allen GP, Deao KM, Hill SA, Schipelliti SM, Tran T |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2021.106417 |
2021 |
* |
Pathogenicity |
Octenidine/carbenicillin GUMBOS as potential treatment for oropharyngeal gonorrhoea. |
Lopez KM, Hobden JA, Warner IM |
J Antimicrob Chemother |
10.1093/jac/dkaa346 |
2020 |
* |
Metabolism |
Comparative Proteomics of Extended-Spectrum Cephalosporin-Resistant Neisseria gonorrhoeae Isolates Demonstrates Altered Protein Synthesis, Metabolism, Substance Transport, and Membrane Permeability. |
Diao N, Yan G, Yang Y, Dong Y, Wang Y, Gu W |
Front Microbiol |
10.3389/fmicb.2020.00169 |
2020 |
* |
Cultivation |
Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin. |
Miller AA, Traczewski MM, Huband MD, Bradford PA, Mueller JP |
J Clin Microbiol |
10.1128/JCM.00567-19 |
2019 |
* |
Genetics |
Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan. |
Jabeen K, Bhawan Mal P, Khan E, Chandio S, Jacobsson S, Unemo M |
BMC Infect Dis |
10.1186/s12879-016-1673-1 |
2016 |
* |
Pathogenicity |
Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226. |
Jones RN, Fedler KA, Scangarella-Oman NE, Ross JE, Flamm RK |
Antimicrob Agents Chemother |
10.1128/AAC.00527-16 |
2016 |
* |
Pathogenicity |
In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae. |
Bharat A, Martin I, Zhanel GG, Mulvey MR |
J Infect Chemother |
10.1016/j.jiac.2015.10.002 |
2015 |
* |
Pathogenicity |
Determination of Disk Diffusion and MIC Quality Control Guidelines for Solithromycin, a Novel Fluoroketolide Antibacterial, against Neisseria gonorrhoeae. |
Riedel S, Ross JE, Farrell DJ, Flamm RK, Jones RN |
J Clin Microbiol |
10.1128/JCM.02250-15 |
2015 |
* |
Pathogenicity |
In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates. |
Hauser C, Hirzberger L, Unemo M, Furrer H, Endimiani A |
Antimicrob Agents Chemother |
10.1128/AAC.04536-14 |
2014 |
* |
Pathogenicity |
Coupling electrochemical response of a DNA biosensor with PCR for Neisseria gonorrhoeae detection. |
Verma R, Sood S, Singh R, Sumana G, Bala M, Sharma VK, Samantaray JC, Pandey RM, Malhotra BD |
Diagn Microbiol Infect Dis |
10.1016/j.diagmicrobio.2013.09.010 |
2013 |
* |
Pathogenicity |
Non-cytotoxic nanomaterials enhance antimicrobial activities of cefmetazole against multidrug-resistant Neisseria gonorrhoeae. |
Li LH, Yen MY, Ho CC, Wu P, Wang CC, Maurya PK, Chen PS, Chen W, Hsieh WY, Chen HW |
PLoS One |
10.1371/journal.pone.0064794 |
2013 |
* |
Pathogenicity |
Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China. |
Yuan LF, Yin YP, Dai XQ, Pearline RV, Xiang Z, Unemo M, Chen XS |
Sex Transm Dis |
10.1097/OLQ.0b013e318219cdb5 |
2011 |
* |
Pathogenicity |
Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae. |
Allen GP, Hankins CD |
J Antimicrob Chemother |
10.1093/jac/dkp172 |
2009 |
* |
Enzymology |
In vitro antigonococcal activity of Coscinium fenestratum stem extract. |
Chomnawang MT, Trinapakul C, Gritsanapan W |
J Ethnopharmacol |
10.1016/j.jep.2009.01.036 |
2009 |
* |
Cultivation |
Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control. |
Brown SD, Traczewski MM |
J Clin Microbiol |
10.1128/JCM.02351-06 |
2007 |
* |
Pathogenicity |
Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination. |
Silva MT, Simas SM, Batista TG, Cardarelli P, Tomassini TC |
Mem Inst Oswaldo Cruz |
10.1590/s0074-02762005000700018 |
2006 |
* |
Phylogeny |
Evaluation of the BIOCEN GC agar medium base in antimicrobial susceptibility testing of Neisseria gonorrhoeae. |
Llanes R, Dominguez C, Prat A, Rodriguez C, Valdes EA, Gutierrez O, Guzman D |
Arch Med Res |
10.1016/j.arcmed.2005.03.011 |
2005 |
* |
Pathogenicity |
Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines. The Quality Control Study Group. |
Jones RN, Erwin ME |
Diagn Microbiol Infect Dis |
10.1016/s0732-8893(00)00139-5 |
2000 |
* |
Pathogenicity |
[Antimicrobial susceptibility of Neisseria gonorrhoeae strains determined by disk diffusion]. |
Llanes Caballero R, Acosta Giraldo JC, Sosa Puente J, Guzman Hernandez D, Gutierrez Gonzalez O, Llop Hernandez A |
Rev Cubana Med Trop |
|
1999 |
* |
Pathogenicity |
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Results from multicenter trials. |
Worth S, Erwin ME, Jones RN |
Diagn Microbiol Infect Dis |
10.1016/0732-8893(95)00276-6 |
1996 |
* |
Pathogenicity |
Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116)). |
Sewell DL, Barry AL, Allen SD, Fuchs PC, Murray PR, Tenover FC |
J Antimicrob Chemother |
10.1093/jac/37.1.139 |
1996 |
* |
Pathogenicity |
Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group. |
Bale MJ, Jones RN, Erwin ME |
Diagn Microbiol Infect Dis |
10.1016/0732-8893(94)90054-x |
1994 |
* |
Pathogenicity |
Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group. |
Bale MJ, Jones RN |
J Clin Microbiol |
10.1128/jcm.31.9.2538-2540.1993 |
1993 |
* |
Pathogenicity |
Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters. |
Barry AL, Fuchs PC, Allen SD, Jorgensen JH, Tenover FC, Murray PR, Hardy DJ, Baker CN |
J Clin Microbiol |
10.1128/jcm.31.9.2375-2380.1993 |
1993 |
* |
Pathogenicity |
Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinations. |
Fuchs PC, Barry AL, Baker CN, Murray PR, Washington JA |
J Clin Microbiol |
10.1128/jcm.30.8.2191-2194.1992 |
1992 |
* |
Pathogenicity |
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin. |
Erwin ME, Jones RN, Koontz FP, Gerlach EH, Murray PR, Washington JA |
J Clin Microbiol |
10.1128/jcm.30.5.1317-1319.1992 |
1992 |
* |
Pathogenicity |
Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin. |
Barry AL, Cohen MA, Sesnie JC, Fuchs PC, Washington JA, Murray PR, Baker C |
J Clin Microbiol |
10.1128/jcm.30.4.813-816.1992 |
1992 |
* |
Pathogenicity |
Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae. |
Fuchs PC, Barry AL, Baker C, Murray PR, Washington JA |
J Clin Microbiol |
10.1128/jcm.30.4.1024-1026.1992 |
1992 |
* |
Pathogenicity |
Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin. |
Fuchs PC, Barry AL, Baker C, Murray PR, Washington JA 2nd |
J Clin Microbiol |
10.1128/jcm.29.10.2111-2114.1991 |
1991 |
* |
Cultivation |
Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline. |
Jones RN, Gavan TL, Thornsberry C, Fuchs PC, Gerlach EH, Knapp JS, Murray P, Washington JA 2nd |
J Clin Microbiol |
10.1128/jcm.27.12.2758-2766.1989 |
1989 |
* |
Pathogenicity |
Antimicrobial Activity of Auranofin, Cannabidivarin, and Tolfenamic Acid against Multidrug-Resistant Neisseria gonorrhoeae. |
Yang F, Liu J, Gu Y, Jiao R, Yan J, Gao S, Lin X, van der Veen S |
Microbiol Spectr |
10.1128/spectrum.03952-22 |
2022 |
* |
|
In Vitro and In Vivo Activities of TP0480066, a Novel Topoisomerase Inhibitor, against Neisseria gonorrhoeae. |
Masuko A, Takata I, Fujita K, Okumura H, Ushiyama F, Amada H, Sugiyama H |
Antimicrob Agents Chemother |
10.1128/AAC.02145-20 |
2021 |
* |
|
Increasing Trend of Resistance to Penicillin, Tetracycline, and Fluoroquinolone Resistance in Neisseria gonorrhoeae from Pakistan (1992-2009). |
Jabeen K, Nizamuddin S, Irfan S, Khan E, Malik F, Zafar A |
J Trop Med |
10.1155/2011/960501 |
2011 |
* |
|
- References
-
#3508 |
Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ;
DSM 9189
|
-
-
-
#36023 |
; Curators of the CIP;
|
-
#48390 |
Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG;
CCUG 26213
|
-
-
#68377 |
Automatically annotated from API NH .
|
-
#68382 |
Automatically annotated from API zym .
|
-
#69479 |
João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.:
MicrobeAtlas 1.0 beta
.
|
-
-
-
#79748 |
Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.:
StrainInfo: A central database for resolving microbial strain identifiers
.
(
DOI 10.60712/SI-ID42367.1 )
|
-
#119706 |
Collection of Institut Pasteur ; Curators of the CIP;
CIP 107031
|
- * These data were automatically processed and therefore are not curated
Change proposal
Successfully sent
|